For citations:
Chazova I.E., Martynyuk T.V., Rodnenkov O.V., Gorieva S.B., Rogoza A.N., Arkhipov M.V., Grinshtein Y.I., Ostroumova O.D., Galiavich A.S., Rotar’ O.P., Khaisheva L.A., Kameneva T.R. Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II. Systemic Hypertension. 2020;17(3):59-70. (In Russ.) https://doi.org/10.26442/2075082X.2020.3.200414
Email this article 